Article Information
History
- June 14, 2021.
Article Versions
- Version 1 (May 31, 2021 - 18:42).
- Version 2 (June 12, 2021 - 22:54).
- You are viewing Version 3, the most recent version of this article.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY 4.0 International license.
Author Information
- A.J. Venkatakrishnan1,+,*,
- Praveen Anand2,+,
- Patrick Lenehan1,
- Pritha Ghosh2,
- Rohit Suratekar2,
- Abhishek Siroha2,
- Dibyendu Roy Chowdhury1,
- John C. O’Horo3,
- Joseph D. Yao3,
- Bobbi S. Pritt3,
- Andrew Norgan3,
- Ryan T. Hurt3,
- Andrew D. Badley3,
- John D. Halamka3 and
- Venky Soundararajan1,2,*
- 1nference, Cambridge, Massachusetts 02139, USA
- 2nference Labs, Bengaluru, Karnataka, India
- 3Mayo Clinic, Rochester, Minnesota 55902, USA
- ↵*Correspondence to: Venky Soundararajan (venky{at}nference.net), A.J. Venkatakrishnan (aj{at}nference.net)
↵+ Equal first authors
Posted June 14, 2021.
Antigenic minimalism of SARS-CoV-2 is linked to surges in COVID-19 community transmission and vaccine breakthrough infections
